Study reveals limitations of large language models in medical diagnostics
View as a Web Page
News Medical
 
  Radiology Radiology logo  
  The latest radiology news from News Medical  
 New AI tool aims to ease prostate cancer diagnostic workloadNew AI tool aims to ease prostate cancer diagnostic workload
 
Increasing use of blood tests to detect prostate cancer is leading to overworked doctors. NTNU has now created an AI diagnostic tool that can help lighten the burden.
 
 
 Study reveals limitations of large language models in medical diagnosticsStudy reveals limitations of large language models in medical diagnostics
 
Artificial intelligence (AI) is rapidly transforming healthcare. AI systems can now detect diabetic eye disease from retinal photos and analyze CT images for signs of early-stage lung cancers and stroke.
 
   MIND diet may protect against structural brain deteriorationMIND diet may protect against structural brain deterioration
 
The combined Mediterranean and blood pressure lowering diet (MIND) may slow the structural changes related to brain aging, finds research published online in the Journal of Neurology Neurosurgery & Psychiatry.
 
   Using machine learning to identify individuals at risk for intimate partner violenceUsing machine learning to identify individuals at risk for intimate partner violence
 
Researchers at Mass General Brigham have developed a series of artificial intelligence (AI) tools that uses machine learning to identify individuals who may be at risk for intimate partner violence (IPV) using information from their electronic medical records (EMRs).
 
   Stress hormones disrupt the internal GPS system of the brainStress hormones disrupt the internal GPS system of the brain
 
Persons under stress may have a harder time spatially orienting themselves. Researchers in Bochum have discovered why.
 
 New AI system reduces pathologist workload while maintaining diagnostic accuracy
 
New AI system reduces pathologist workload while maintaining diagnostic accuracyArtificial intelligence could make cancer diagnosis safer and fairer by learning when to defer to human pathologists without overloading them, according to researchers from the University of Surrey and Monash University.
 
 
 Families scramble to pay five-figure bills as clock ticks on promised preauthorization reforms
 
Families scramble to pay five-figure bills as clock ticks on promised preauthorization reformsSheldon Ekirch is used to being disappointed by her health insurance company.
 
 
 Aptamer Group launches targeted radiopharmaceutical program
 
Aptamer Group launches targeted radiopharmaceutical programAptamer Group plc, the developer of next‑generation synthetic binders for the life sciences industry, today announced the launch of a new targeted radiopharmaceutical program in collaboration with Radiopharmium Ltd, a UK-based specialist consultancy in radiopharmaceutical development.
 
 
 Iconeus expands U.S. presence to support growing adoption of fUS in preclinical brain imaging
 
Iconeus expands U.S. presence to support growing adoption of fUS in preclinical brain imagingIconeus, a French neuroimaging company developing functional ultrasound (fUS) solutions for real-time brain activity imaging, today announced the creation of its U.S. entity, Iconeus Inc. – a key milestone in supporting the adoption of functional ultrasound in preclinical neuroscience research.
 
 
 SonoPIN technology boosts intracellular delivery of large cancer drugs
 
SonoPIN technology boosts intracellular delivery of large cancer drugsEngineers at Duke University have demonstrated a technique that uses microbubbles and ultrasound to help relatively large cancer drugs enter tumor cells and cause them to self-destruct.
 
 
 Clinical trial tests a newer, targeted therapy for IDH mutant astrocytoma
 
A new clinical trial led by the Alliance for Clinical Trials in Oncology will investigate if a combination of drug therapies after radiation therapy improves outcomes for people with newly-diagnosed, grade 3 IDH-mutant astrocytoma, a type of brain cancer.
 
 
 Robot-assisted system found to be feasible for diagnostic cerebral angiography
 
Robot-assisted system found to be feasible for diagnostic cerebral angiographyDigital subtraction angiography remains the gold standard for diagnosing cerebrovascular diseases, including intracranial aneurysms, arteriovenous malformations, and arterial stenosis.
 
 
 Boosting noradrenaline during learning makes the brain link memories more broadly, study finds
 
Boosting noradrenaline during learning makes the brain link memories more broadly, study findsA randomized placebo controlled experiment shows that increasing noradrenaline during learning does not improve basic memory accuracy but increases the spread of associations across the hippocampal cognitive map. This broader neural linking leads to greater overgeneralization errors days later, suggesting that noradrenergic arousal can reshape how related memories become interconnected.
 
 
 New approach developed to visualize proteins at unprecedented scale and sensitivity
 
New approach developed to visualize proteins at unprecedented scale and sensitivityProteins, one of the smallest building blocks of life on Earth, hold promise for answering some of biology's biggest questions.
 
 
 PSMA PET/CT scan may halve unnecessary prostate biopsies
 
An imaging test could safely halve the number of people who need a biopsy for suspected prostate cancer following inconclusive or reassuring results from an MRI scan, new research has found.
 
 
 International urology conference showcases advancements in prostate cancer diagnostics
 
Nearly 300 abstracts on prostate cancer research from around the world will be presented at the European Association of Urology Congress (EAU26), taking place in London from 13–16 March 2026.
 
 
 Defining the limits of immunotherapy in early small-cell lung cancer
 
Immunotherapy given during and after chemoradiation did not improve survival for study participants with limited-stage, small-cell lung cancer (SCLC) according to the results of an international clinical trial, NRG-LU005, led by NRG Oncology in collaboration with the Alliance for Clinical Trials in Oncology. The results are published in the Journal of Clinical Oncology.
 
 
 Transforming prostate screening into a global gold standard
 
Prostate cancer screening compares favourably to screening for breast cancer in identifying significant cancers, reducing mortality and avoiding unnecessary harms, says new research.
 
Facebook X Instagram LinkedIn Vimeo
Why did you receive this email?
You are receiving this email because you subscribed to updates from AZoNetwork UK Ltd. on one of our websites and requested to be notified of additional information.

Unsubscribe or Update Notification Preferences

Contact | About | Privacy Policy

- - - - - -

Registered Address:
AZoNetwork UK Ltd., NEO, 9 Charlotte St, Manchester, M1 4ET, UK

Manchester | Sydney | Boston

Copyright © 2000-2026